Delivery Order SPE2DB20D9127-SPE2DB21FD3WS

Award Date 9/24/21
Potential Completion Date 10/18/21
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,858.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,566,777,090 units of the contraceptive implant Nexplanon. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to procure a wide range of pharmaceutical products,...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,432.21 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,017,607 units of the contraceptive implant Nexplanon 68 mg. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that the DLA has with DMS Pharmaceutical Group to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $5,033.44 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,557,298,149 units of the Nexplanon 68 mg implant, a contraceptive device. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which covers a wide range of branded and generic...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,858.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,565,480 units of the contraceptive implant Nexplanon 68 mg. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $17,867.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,343 units of the contraceptive implant NEXPLANON 68 MG IMPLANTS, with a period of performance through November 25, 2024. This delivery order falls under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $34,305.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,735,287 units of the contraceptive implant Nexplanon 68 mg. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $34,305.12 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of 4,566,661,182 units of the contraceptive implant Nexplanon (68 mg) to support the recurring medical supply needs of military healthcare facilities. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $35,734.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,068,971 Nexplanon 68 mg contraceptive implants. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued at up to $4,999,999 through the end of 2025. The IDV enables...
This is a $5,717.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the procurement of 4,564,764,375 units of the contraceptive implant Nexplanon 68 mg, with a period of performance through June 14, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $12,864.42 to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,257,903 units of the contraceptive implant NEXPLANON 68 MG by May 1, 2024. This delivery order is part of a larger five-year indefinite delivery, indefinite quantity (IDIQ) contract, SPE2DB24D9238|SPE2DB24FDQDS, valued at up to...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB21FD3WS
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $6,259.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is for the supply of 4,554,941 units of the contraceptive implant Nexplanon 68 mg. This order was issued under an Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which enables the agency to procure a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military healthcare facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories.

Generated 2/27/25, 9:52 AM